Maribavir
(2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol
Molecular Identity
Maribavir
(2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol
PubChem CID: 471161
2D Structure
Properties
C15H19Cl2N3O4
Molecular Formula
376.20
Molecular Weight
g/mol
375.0753
Exact Mass
Da
2.2
XLogP
Drug-like (Lipinski: < 5)
99.8
TPSA
Good oral absorption (< 140 A²)
4
H-Bond Donors
6
H-Bond Acceptors
447
Complexity
SMILES
Canonical SMILES
SMILES: CC(C)NC1=NC2=CC(=C(C=C2N1C3C(C(C(O3)CO)O)O)Cl)ClIsomeric SMILES
SMILES: CC(C)NC1=NC2=CC(=C(C=C2N1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)ClSynonyms(20)
Maribavir176161-24-3Benzimidavirlivtencity1263W94CamviamaribavirumBW-1263W94GW-257406X(2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diolGW-1263PTB4X93HE1BW 1263W941263-W-94DTXSID60170091
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Maribavir
Loading drug network...